Gliclazide 60 mg Modified Release Tablets Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Gliclazide 60 mg Modified Release Tablets Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Second-generation sulphonylurea (Gliclazide-based)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Gliclazide 60 mg Modified Release Tablets Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Gliclazide 60 mg Modified Release Tablets Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Gliclazide 60 mg Modified Release Tablets Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Gliclazide 60 mg Modified Release Tablets formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Type-2 diabetes mellitus
- Adjunct to metformin
- Diabetic patients with vascular risk (gliclazide's antioxidant benefit)
Mechanism of Action
Gliclazide is a second-generation sulphonylurea that stimulates pancreatic beta-cell insulin secretion by closing ATP-sensitive K+ channels (SUR1). It also has antioxidant and antiplatelet effects via free-radical scavenging and reduced platelet aggregation — providing additional benefit in diabetic vascular complications.
Dosage & Administration
- Adults: 1 tablet once daily before breakfast (or as advised)
- Titrate based on glycaemic response
- Maximum 320 mg/day total gliclazide
- MR tablets: swallow whole, do not crush
Side Effects
- Hypoglycaemia
- Weight gain (mild)
- GI upset
- Skin reactions (rare)
- Cholestatic jaundice (rare)
Contraindications
- Type-1 diabetes
- Diabetic ketoacidosis
- Severe hepatic/renal impairment
- Pregnancy and breastfeeding
- Sulphonamide hypersensitivity
Storage
Store below 25°C.
PCD Pharma Franchise for Gliclazide 60 mg Modified Release Tablets Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 4 x 5 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Gliclazide 60 mg Modified Release Tablets Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Gliclazide 60 mg Modified Release Tablets Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Gliclazide 60 mg Modified Release Tablets Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Gliclazide 60 mg Modified Release Tablets Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Gliclazide 60 mg Modified Release Tablets Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Gliclazide 60 mg Modified Release Tablets Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Gliclazide 60 mg Modified Release Tablets Tablet?
Available pack sizes include: 4 x 5 x 10 (Blister).
What is the MRP / trade price for Gliclazide 60 mg Modified Release Tablets Tablet?
MRPs range from ₹1100 to ₹1100 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Gliclazide 60 mg Modified Release Tablets Tablet?